loader image

Global Regenerative Trade

TriAlpha CO orders 300 BMAC kits after a successful GOB training in Kuwait

The Global OrthoBiologic Inc. (GOB) team just returned home after one week training in Kuwait.  Our team was represented by company President Mr. Randy Beimel, VP International Business Development Mr. Mihail Blagoev, scientific officer Dr. Dzihan Abazovic and Dr. Fabio Valerio Sciarretta. The team visited different hospitals every day, giving presentations and lecturing in front of large audiences. The training was organized as per Tri Alpha Company invitation. They are the GOB official distributor for Kuwait. Tri Alpha Co is consistently committed to provide the best medical supply solutions in the region, and this is one of the reasons they decided to enter into a distribution contract with GOB. Creating solid and enduring relationships with our principals through our continuous commitment to meet and exceed their expectations is our shared goal. The GOB team visit in Kuwait began on February 7th with a lecture in Al-Razi Hospital and continued with a lecture in AL-Amiri hospital. On that same day we had also a very successful presentation in Dasman Center.

GOB agreed with the clinical director of Dasman Diabetic Center to begin a clinical project of wounds in lower extremities for diabetic patients. The Kuwait Ministry Of Health will support the project.

Al-Razi Hospital was our main venue for live streaming of the procedures we were presenting. Central to the visit was Dr. Fabio Sciarretta, who was sponsored by MOH Kuwait to perform training and presentation to the team at the hospital. He performed 5 surgeries and 3 presentations with a hands-on workshop for an “osteochondral cartilage defect” during his last presentation. Dr. Dzihan Abazovic, GOB Scientific Officer, assisted Dr. Sciarretta during the surgeries and answered scientific questions posed by the audience with regards to the potential of the Autologous Regenerative Therapies.

Dr. Sciarretta’s presentation on “Single Step Biological Resurfacing of Knee Chondral Defects through Innovative Bone Marrow Concentration Device” inspired the audience with all the advanced methods of this procedure.

Tri Alpha Co introduced both of our doctors to few private clinics in Kuwait. The GOB team visited also Mubarak Hospital, Farwaniya Hospital and the office of Dr. Jasen Failkawi for another lecture.

Our distributors from Tri Alpha Co regularly invite European visiting doctors to perform innovative procedures for local medical professionals and this keeps them as one of the top distribution companies in Kuwait. GOB was pleased to work with such a professional team!

As soon as the visits concluded, Al Razi Hospital made a purchase order for 300 BMAC kits and this was considered a great success for Tri Alpha Co and GOB after only the first training program!

About Tri Alpha

Tri Alpha strides towards attaining customer satisfaction through the introduction of uncompromised and unparalleled quality products supported by after sales service. Our business strategy is to achieve major market shares and maintaining a strong products and maintenance portfolio. Our expansion plan is horizontally driven and we intend to expand in the areas where we can make a difference. Tri Alpha is managed by a vibrant, experienced and knowledgeable team. In addition to their personal educational background and deep interest in their field, Mr. Ahmed Al-Awadi, Founder & General Manager, along with Ms. Fatima Al-Awadi, Assistant GM, come from a family that is well entrenched in public health sector, medical field, and environmental preservation. The sector managers are committed to the company’s visionary business strategy to provide quality products and services to their government and corporate clients alike.

Vivostat Logo

THE VIVOSTAT® SYSTEM

The uniqueness of the Vivostat® system is a novel patented biotechnological process that enables reliable and reproducible preparation of autologous Fibrin Sealant or Platelet Rich Fibrin (PRF®) without using cryoprecipitation and without the need for a separate thrombin component.

THE FULLY AUTOMATED VIVOSTAT® SYSTEM CONSISTS OF THREE COMPONENTS:

  • The Processor Unit is a non-sterile, reusable, fully automated device that controls the biochemical process.
  • The Processor Unit is used to process the patient’s blood and prepare the Vivostat® Fibrin Sealant or Vivostat PRF® solution.
Vivostat Processor Product
  • The Processor Unit is operated by a single button and a display keeps the nurse informed of the remaining process time and status at all times. No specific installation is required and the large wheelbase makes moving it easy.
  • The Processor Unit can be located in any room or corridor in the operating department. It is most often placed centrally between the operating theatres. This way one Processor Unit can supply a number of operating theatres.
  • In approx.  25 min a concentrated fibrin sealant or PRF® solution is prepared from the patient’s whole blood.
  • The Applicator Unit is a non-sterile, reusable, fully automated device that controls the delivery of the Vivostat® Fibrin Sealant or Vivostat PRF®.
Vivostat Processor Product
  • The large display and integrated microprocessor automatically primes the Spraypen® and informs the surgeon of the remaining volume of fibrin sealant/PRF® throughout the entire process.
  • Different spray modes can be selected depending on the actual procedure or area to be covered. Like the Processor Unit it has a large wheelbase and can easily be moved if required.
  • The disposable set comprises of two parts: A Preparation Kit used to prepare the fibrin sealant or PRF® solution before surgery, and an Application Kit used to activate and apply the fibrin sealant/PRF® solution.

 

  • Preparation Kit
    The Preparation Kit contains the specially designed Preparation Unit – a sterile disposable device in which the patient’s blood is collected, the biochemical process carried out, and the fibrin sealant or PRF® solution harvested.

 

  • The Application Kit
    The Application Kit contains the Spraypen®1 and all other items required to prepare the system for the delivery of the fibrin sealant or PRF® solution. The Spraypen® is a sterile, disposable, hand held device which delivers the fibrin sealant or PRF® solution to the tissue. The revolutionary and patented design offers the surgeon unparalleled freedom in controlling the application unlike any other product on the market today.

 

1Besides the Spraypen®, the Vivostat® system offers different types of applicators, e.g. the Endoscopic Applicator. For a full list of application devices click here

1-2-3 Spray

Three easy steps to prepare Vivostat® Fibrin Sealant or Vivostat PRF®

1. Draw blood from the Patient

Fibrin Prep With Blood Inside

At the time of surgery or up to 24 hours before1, citrate (supplied with the kit) is added to the Preparation Unit. 120 ml of the patient’s own blood is then drawn into the same unit.

2. Process the patient’s blood

Vivostat Processor 800

The Preparation Unit is placed in the Processor Unit. At the touch of a button the process starts; after approx. 25 minutes, an autologous fibrin or PRF® solution is ready for use. No thrombin or bovine components are added to the blood at any time.

3. Load the Applicator Unit and spray

Vivostat Display Applicator

The Fibrin or PRF® solution is easily loaded into the Applicator Unit and applied to the surgical site using one of the unique application devices (e.g. the Spraypen). 1This depends on the type of kit being used. Always consult the “Instructions for Use” supplied with the kit to determine the correct preparation.

The following video illustrates how to prepare and apply autologous fibrin sealant.

Presentation DVD from Vivostat A/S on Vimeo.